Endovascular Treatment for Tentorial Dural Arteriovenous Fistulas: A Retrospective Single-Center Study.

Guanghao Zhang, Miao Pang, Zhe Li, Chenghao Shang, Yuhang Zhang, Qi Zhang, Qinghai Huang, Yi Xu, Guoli Duan, Qiang Li, Jianmin Liu
{"title":"Endovascular Treatment for Tentorial Dural Arteriovenous Fistulas: A Retrospective Single-Center Study.","authors":"Guanghao Zhang, Miao Pang, Zhe Li, Chenghao Shang, Yuhang Zhang, Qi Zhang, Qinghai Huang, Yi Xu, Guoli Duan, Qiang Li, Jianmin Liu","doi":"10.3174/ajnr.A8676","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Current evidence suggests that tentorial dural arteriovenous fistulas with endovascular treatment offer a high rate of occlusion and reduced procedural risks. We report the clinical and angiographic outcomes in patients with tentorial dural arteriovenous fistulas who underwent endovascular treatment as first-line treatment.</p><p><strong>Materials and methods: </strong>A retrospective analysis was conducted on 83 patients with tentorial dural arteriovenous fistulas treated at our center from April 2009 to November 2023 by using endovascular treatment. Patient demographics, clinical presentations, angiographics, treatment results, and follow-up outcomes were registered. Univariable and multivariable logistic regression were performed to identify the onset of intracranial hemorrhage predictors, procedure-related complications predictors, and predictors of poor functional outcome.</p><p><strong>Results: </strong>Eighty-three patients underwent endovascular treatment as first-line treatment. Most patients (80.7%) were symptomatic, and a total of 25 patients (30.1%) presented with intracranial hemorrhage. The presence of deep venous drainage and midline location were associated with a lower incidence of intracranial hemorrhage. Middle meningeal artery (57.8%, 48/83) and pial artery (15.7%, 13/83) were the most frequently used access routes for embolization. A total of 74 (89.1%) tentorial dural arteriovenous fistulas were completely occluded immediately after the last endovascular treatment session. Complications occurred in 11 patients (13.3%). Six-month angiographic follow-up was performed in 68 patients (81.8%), and 91.2% (62/68) of tentorial dural arteriovenous fistulas were occluded. At clinical follow-up (100%, 83/83), good functional outcome (mRS 0-2) was documented in 74 (89.1%) patients. Logistic regression analysis identified baseline mRS 3-5 as the most significant independent predictor of poor functional outcome. Subgroup analysis showed no statistically significant differences in baseline characteristics, angiography, and clinical results between patients treated with targeted pial artery embolization and nontargeted pial artery embolization.</p><p><strong>Conclusions: </strong>Endovascular treatment is a safe and effective primary technique for managing tentorial dural arteriovenous fistulas, achieving high rates of complete angiographic occlusion and favorable functional outcomes. Transarterial embolization, predominantly via the middle meningeal artery, was the mainstay of treatment. In patients with pial arterial feeders, omitting aggressive embolization did not compromise efficacy or increase complications.</p>","PeriodicalId":93863,"journal":{"name":"AJNR. American journal of neuroradiology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AJNR. American journal of neuroradiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3174/ajnr.A8676","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and purpose: Current evidence suggests that tentorial dural arteriovenous fistulas with endovascular treatment offer a high rate of occlusion and reduced procedural risks. We report the clinical and angiographic outcomes in patients with tentorial dural arteriovenous fistulas who underwent endovascular treatment as first-line treatment.

Materials and methods: A retrospective analysis was conducted on 83 patients with tentorial dural arteriovenous fistulas treated at our center from April 2009 to November 2023 by using endovascular treatment. Patient demographics, clinical presentations, angiographics, treatment results, and follow-up outcomes were registered. Univariable and multivariable logistic regression were performed to identify the onset of intracranial hemorrhage predictors, procedure-related complications predictors, and predictors of poor functional outcome.

Results: Eighty-three patients underwent endovascular treatment as first-line treatment. Most patients (80.7%) were symptomatic, and a total of 25 patients (30.1%) presented with intracranial hemorrhage. The presence of deep venous drainage and midline location were associated with a lower incidence of intracranial hemorrhage. Middle meningeal artery (57.8%, 48/83) and pial artery (15.7%, 13/83) were the most frequently used access routes for embolization. A total of 74 (89.1%) tentorial dural arteriovenous fistulas were completely occluded immediately after the last endovascular treatment session. Complications occurred in 11 patients (13.3%). Six-month angiographic follow-up was performed in 68 patients (81.8%), and 91.2% (62/68) of tentorial dural arteriovenous fistulas were occluded. At clinical follow-up (100%, 83/83), good functional outcome (mRS 0-2) was documented in 74 (89.1%) patients. Logistic regression analysis identified baseline mRS 3-5 as the most significant independent predictor of poor functional outcome. Subgroup analysis showed no statistically significant differences in baseline characteristics, angiography, and clinical results between patients treated with targeted pial artery embolization and nontargeted pial artery embolization.

Conclusions: Endovascular treatment is a safe and effective primary technique for managing tentorial dural arteriovenous fistulas, achieving high rates of complete angiographic occlusion and favorable functional outcomes. Transarterial embolization, predominantly via the middle meningeal artery, was the mainstay of treatment. In patients with pial arterial feeders, omitting aggressive embolization did not compromise efficacy or increase complications.

脑幕硬膜动静脉瘘的血管内治疗:一项回顾性单中心研究。
背景和目的:目前的证据表明,经血管内治疗的小脑幕硬膜动静脉瘘闭塞率高,手术风险低。在这里,我们报告了接受血管内治疗作为一线治疗的小脑幕硬膜动静脉瘘患者的临床和血管造影结果。材料与方法:回顾性分析2009年4月至2023年11月在我中心行血管内治疗的脑幕硬膜动静脉瘘83例。记录了患者的人口统计学、临床表现、血管造影、治疗结果和随访结果。采用单变量和多变量logistic回归来确定颅内出血的发病预测因素、手术相关并发症预测因素和功能不良预后预测因素。结果:83例患者行血管内治疗为一线治疗。大多数患者(80.7%)有症状,共25例(30.1%)出现颅内出血。深静脉引流和中线位置的存在与颅内出血发生率较低有关。脑膜中动脉(57.8%,48/83)和头动脉(15.7%,13/83)是最常用的栓塞通路。最后一次EVT治疗后,74例(89.1%)tdavf立即完全闭塞。并发症11例(13.3%)。68例(81.8%)患者进行了6个月的血管造影随访,91.2%(62/68)的脑膜小幕动静脉瘘被封堵。在临床随访中(100%,83/83),74例(89.1%)患者有良好的功能预后(mRS 0-2)。Logistic回归分析发现基线mRS 3-5是功能不良预后最显著的独立预测因子。亚组分析显示,行靶向性动脉栓塞与非靶向性动脉栓塞患者的基线特征、血管造影及临床结果均无统计学差异。结论:血管内治疗是治疗小脑幕硬膜动静脉瘘的一种安全有效的主要方式,血管造影完全闭塞率高,功能预后良好。经动脉栓塞,主要通过中脑膜动脉,是主要的治疗方法。在使用动脉输注器的患者中,省略积极栓塞并不影响疗效或增加并发症。DAVF =硬脑膜动静脉瘘;幕状硬脑膜动静脉瘘;EVT =血管内治疗;TAE =经动脉栓塞;经静脉栓塞;MMA =脑膜中动脉。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信